Category Archives: Drug Side Effects

This film image released by Open Road Films shows Jude Law in a scene from "Side Effects." (AP Photo/Open Road Films) DVD review: Side Effects is a smooth, sly thriller By Sean P. Means | The Salt Lake Tribune Grade B DVD If Steven Soderbergh is retiring from moviemaking, as hes claimed, the thriller "Side Effects" isnt a bad way to go out. It starts with frail Emily (Rooney Mara) feeling depressed when her husband Martin (Channing Tatum) finishes a prison term for insider trading. Emily sees a shrink, Dr. Jonathan Banks (Jude Law), who prescribes a new anti-depressant but the drugs side effects include sleepwalking, or for Emily sleep-stabbing. Soderbergh puts a smooth polish on Scott Z. Burns script, which has some clever twists and sly commentary about pharmaceutical-industry marketing. Mara ("The Girl With the Dragon Tattoo") holds the wild plot together with her quicksilver performance. Copyright 2013 The Salt Lake Tribune. All rights reserved. This material may not be published, broadcast, rewritten or redistributed. Read more here: DVD review: ‘Side Effects’ is a smooth, sly thriller … Continue reading →

New DVDs From Side Effects to The Last Stand, theyre back and available on DVD Tuesday. Star ratings are by Seattle Times movie reviewers, freelancers or wire services. For full reviews, search the movie title at seattletimes.com. Release dates are subject to change. Side Effects (R): The less you know in advance about Steven Soderberghs slick thriller, the more youll enjoy it, says Seattle Times movie critic Moira Macdonald. Starring Rooney Mara and Channing Tatum as a married couple and Jude Law as a psychiatrist who prescribes a new drug, it surprises from beginning to end. Parker (R): Jason Statham and Jennifer Lopez team up for director Taylor Hackfords heist thriller, which follows a crook with a rigid moral code who plots payback after being betrayed. Yossi (not rated; for mature audiences): The sequel to Yossi & Jagger looks at a former Israeli soldier (Ohad Knoller) struggling to move on from the loss of his lover, who died on the front lines. In Hebrew, with English subtitles. The ABCs of Death (not rated; for mature audiences): This alphabet soup of horror consists of 26 chapters by different directors (A is for Apocalypse, etc.) and involves some form of grisly death. … Continue reading →

The Saudi Food and Drug Authority (SFDA) has canceled the registration of Ritrodine (Yutopar), which is used to stop premature labor. The move came following the recommendation of the commission in charge of the registration of approved pharmaceutical companies and products, as the medication was found to have serious side effects including cardiac arrhythmias, myocardial ischemia, pulmonary edema, palpitation and tachycardia. The commission has asked health practioners and health care providers to discontinue using the drug and use other medicines suitable for pregnant women who need to stop premature labor. In addition, it has contacted the authorities to remove the drug from the Saudi market and requested health practitioners to report any undesirable side effects of any drug to NPC.Drug@sfda.gov.sa. Meanwhile, the SFDA recently announced that there are 1,098 unlicensed companies that import medical equipment into the Kingdom. The number of local companies that import medical equipment across the Kingdom is 1,679, but only 581 of them are licensed. The rest of the companies import equipment without authorization, said Saleh Al-Tayyar, vice executive president for medical devices sector in the SFDA. The SFDA received more than 10,000 notifications about faulty equipment since 2008 and rejected around 1.24 percent of medical … Continue reading →

By Matthew Perone, The Associated Press Federal health regulators say an experimental insomnia drug from Merck can help patients fall asleep, but it also carries worrisome side effects, including daytime drowsiness and suicidal thinking. The Food and Drug Administration on Monday released its review of the company's sleep aid, suvorexant, ahead of a public meeting on Wednesday. The pill works by temporarily blocking chemical messengers that keep people awake. The FDA said company trials show suvorexant is better than placebo at helping people fall asleep and stay asleep. And regulators said the drug's effectiveness was consistent across several doses tested by Merck & Co. Inc. But patients taking the higher doses of the drug showed an eight-fold increase in daytime drowsiness, which sometimes interfered with driving the next morning. Patients taking 20 milligrams and 40 milligrams of suvorexant had trouble staying in their driving lanes when tested by company researchers. FDA notes that four women actually had to stop the driving test due to excessive sleepiness. The FDA review also notes that suvorexant was associated with increased risk of suicidal thinking. Over 12 months, there were eight cases of suicidal thinking or behavior reported among patients taking the drug, compared … Continue reading →

MATTHEW PERRONE , The Associated Press Posted: Monday, May 20, 2013, 11:53 AM WASHINGTON - Federal health regulators say an experimental insomnia drug from Merck can help patients fall asleep, but it also carries worrisome side effects, including daytime drowsiness and suicidal thinking. The Food and Drug Administration on Monday released its review of the company's sleep aid, suvorexant, ahead of a public meeting on Wednesday. The pill works by temporarily blocking chemical messengers that keep people awake. The FDA said company trials show suvorexant is better than placebo at helping people fall asleep and stay asleep. And regulators said the drug's effectiveness was consistent across several doses tested by Merck & Co. Inc. But patients taking the higher doses of the drug showed an eight-fold increase in daytime drowsiness, which sometimes interfered with driving the next morning. Patients taking 20 milligrams and 40 milligrams of suvorexant had trouble staying in their driving lanes when tested by company researchers. FDA notes that four women actually had to stop the driving test due to excessive sleepiness. The FDA review also notes that suvorexant was associated with increased risk of suicidal thinking. Over 12 months, there were eight cases of suicidal thinking … Continue reading →

By Matthew Perone, The Associated Press Federal health regulators say an experimental insomnia drug from Merck can help patients fall asleep, but it also carries worrisome side effects, including daytime drowsiness and suicidal thinking. The Food and Drug Administration on Monday released its review of the company's sleep aid, suvorexant, ahead of a public meeting on Wednesday. The pill works by temporarily blocking chemical messengers that keep people awake. The FDA said company trials show suvorexant is better than placebo at helping people fall asleep and stay asleep. And regulators said the drug's effectiveness was consistent across several doses tested by Merck & Co. Inc. But patients taking the higher doses of the drug showed an eight-fold increase in daytime drowsiness, which sometimes interfered with driving the next morning. Patients taking 20 milligrams and 40 milligrams of suvorexant had trouble staying in their driving lanes when tested by company researchers. FDA notes that four women actually had to stop the driving test due to excessive sleepiness. The FDA review also notes that suvorexant was associated with increased risk of suicidal thinking. Over 12 months, there were eight cases of suicidal thinking or behavior reported among patients taking the drug, compared … Continue reading →

May 20, 2013 A new study of both computer-created and natural proteins suggests that the number of unique pockets -- sites where small molecule pharmaceutical compounds can bind to proteins -- is surprisingly small, meaning drug side effects may be impossible to avoid. The study also found that the fundamental biochemical processes needed for life could have been enabled by the simple physics of protein folding. Studying a set of artificial proteins and comparing them to natural proteins, researchers at the Georgia Institute of Technology have concluded that there may be no more than about 500 unique protein pocket configurations that serve as binding sites for small molecule ligands. Therefore, the likelihood that a molecule intended for one protein target will also bind with an unintended target is significant, said Jeffrey Skolnick a professor in the School of Biology at Georgia Tech. "Our study provides a rationalization for why a lot of drugs have significant side effects -- because that is intrinsic to the process," said Skolnick. "There are only a relatively small number of different ligand binding pockets. The likelihood of having geometry in an amino acid composition that will bind the same ligand turns out to be much … Continue reading →

Fullerton Chiropractor Dr Nancy Rippy Health Solutions for You Fullerton Chiropractor http://www.rippychiropractic.com In this video Fullerton Chiropractor Dr. Nancy Rippy discusses all the health solutions she offers he... By: RippyChiropractic … Continue reading →

News Side Effects, Arnold's Comeback Lead New Blu-ray Releases By Swanni Washington, D.C. (May 20, 2013) - The Steven Soderbergh thriller Side Effects leads this week's list of new Blu-ray titles. Side Effects, which stars Jude Law, features a woman (Rooney Mara) who starts having a peculiar reaction to an anxiety drug prescribed by her doctor (Law) after her husband is paroled from prison. What seems to be a quiet drama is then suddenly turned into a Hitchockian murder mystery where everyone is a possible suspect or victim. To order Side Effects for $22.99, click: Side Effects The list of this week's new Blu-ray releases also includes: Arnold Schwarzenegger's comeback film, The Last Stand; the complete fifth season of True Blood; Parker, starring Jason Statham and Jennifer Lopez; Beautiful Creatures; Stand Up Guys; The Burning; and the Rolling Stones' documentary film, Crossfire Hurricane. To see the complete list of this week's Blu-ray releases -- and learn how to order your favorite -- click: Blu-ray Week Also See: Top 100 Blu-Ray Players Today's 10 Best-Selling Blu-ray Titles Continued here: Side Effects, Arnold's Comeback Lead New Blu-ray Releases … Continue reading →

Universal, $29.98; Blu-ray, $34.98 Available on VOD beginning Tuesday Director Steven Soderbergh and screenwriter Scott Z. Burns don't really try to reinvent the psychological thriller with their film. Structurally, it's a conventionally twisty mystery, with Jude Law playing a psychiatrist who goes into investigative mode when one of his patients (Rooney Mara) commits a heinous crime. But Soderbergh and Burns do strike an appealingly low-key tone here, not even tipping their hands that the movie is a genre piece until the second half. They're more interested in the culture of pills and palliatives that Law inhabits, and how it's convinced everyone doctors and patients and loved ones alike that the right combination of medicine and therapies can fix anything. It's a pointed film but no less entertaining for the dose of social commentary. The DVD and Blu-ray tack on a tongue-in-cheek three-minute featurette, and several fake pharmaceutical commercials. Beautiful Creatures Warner Bros., $28.98; Blu-ray, $35.99 Available on VOD beginning Tuesday FULL COVERAGE: Summer sneaks Kami Garcia and Margaret Stohl's young-adult fantasy bestseller is about a small-town South Carolina teen who has a crush on the new girl in school, who turns out to be a practicing magician with an evil … Continue reading →